Retraction notice to “Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole” [Biomedicine & Pharmacotherapy 167 (2023) 115528] - 25/03/26
Doi : 10.1016/j.biopha.2026.119194
Dušica J. Popović a, Kosta J. Popović b, Dejan Miljković c, Jovan K. Popović d, e, ⁎, Dušan Lalošević c, Mihalj Poša b, Zana Dolićanin a, Ivan Čapo c
a Department of Biomedical Sciences, State University of Novi Pazar, Vuka Karadžića 9, 36300 Novi Pazar, Serbia
b Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia
c Department of Histology and Embryology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia
d Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia
e Academy of Medical Sciences of the Serbian Medical Society, 19 George Washington str, 11000 Belgrade, Serbia
⁎ Corresponding author.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 197
Article 119194- avril 2026 Retour au numéro
Article précédent
- Retraction notice to “Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects” [Biomedicine & Pharmacotherapy 176 (2024) 116833]
- Mohammad Ebrahimnezhad, Amir Valizadeh, Maryam Majidinia, Peyman Tabnak, Bahman Yousefi
- Retraction notice to “Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme” [Biomedicine & Pharmacotherapy 141 (2021) 111928]
- Priti Tagde, Pooja Tagde, Sandeep Tagde, Tanima Bhattacharya, Vishal Garg, Rokeya Akter, Md. Habibur Rahman, Agnieszka Najda, Ghadeer M. Albadrani, Amany A. Sayed, Muhammad Furqan Akhtar, Ammara Saleem, Ahmed E. Altyar, Deepak Kaushik, Mohamed M. Abdel-Daim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?